Interactions between Allosteric Modulators and 4-DAMP and Other Antagonists at Muscarinic Receptors: Potential Significance of the Distance between the N and Carboxyl C Atoms in the Molecules of Antagonists

@article{Lyskov2004InteractionsBA,
  title={Interactions between Allosteric Modulators and 4-DAMP and Other Antagonists at Muscarinic Receptors: Potential Significance of the Distance between the N and Carboxyl C Atoms in the Molecules of Antagonists},
  author={Michaela Lys{\'i}kov{\'a} and Zdeněk Havlas and Stanislav Tuc̆ek},
  journal={Neurochemical Research},
  year={2004},
  volume={26},
  pages={383-394}
}
Allosteric enhancement of the affinity of muscarinic receptors for their ligands offers a new way to influence cholinergic neurotransmission. The structure of the allosteric binding domain(s) and the features of agonists, antagonists and modulators which determine the occurrence of either positive or negative cooperativity require clarification. We tested interactions between allosteric modulators alcuronium, strychnine and brucine and eight antagonists at muscarinic receptors expressed in CHO… Expand
Cooperative Interactions at M2 Muscarinic Acetylcholine Receptors: Structure/Activity Relationships in Stepwise Shortened Bispyridinium- and Bis(Ammonio)Alkane-Type Allosteric Modulators
TLDR
The findings are in line with the hypothesis that the phthalimido-moiety, but not the middle chain, is pivotal for the topology of interaction with the M2-receptor protein. Expand
Allosteric Modulation of Muscarinic Acetylcholine Receptors
TLDR
This review summarizes over 30 years of research on the molecular mechanisms of allosteric interactions of drugs with the receptor and for newAllosteric modulators of muscarinic receptors with potential therapeutic use. Expand
Investigating Allosteric Activation of the M1 Muscarinic Acetylcholine Receptor
Allosteric ligands of G protein-coupled receptors (GPCRs) bind to sites that are topographically distinct from the orthosteric site. AC-42 and 77-LH-28-1 are functionally selective Ml muscarinicExpand
Heterotropic cooperativity within and between protomers of an oligomeric M(2) muscarinic receptor.
TLDR
The rates of equilibration and dissociation suggest that the receptor was predominately oligomeric, and the heterogeneity revealed by gallamine can be attributed to differences in its affinity for the constituent protomers of a tetramer. Expand
A Mechanism for Rapacuronium-induced Bronchospasm: M2 Muscarinic Receptor Antagonism
TLDR
A potential mechanism by which rapacuronium may potentiate bronchoconstriction is by blockade of M2 muscarinic receptors on prejunctional parasympathetic nerves, leading to increased release of acetylcholine and thereby resulting in M3 mus carinic receptor–mediated airway smooth muscle constriction. Expand
Allosteric Drugs Acting at Muscarinic Acetylcholine Receptors
TLDR
A theoretical and practicable definition of allosteric drugs acting at muscarinic receptors will be given in this work, together with a summary of recent data concerning the number, position, and structural requirements of their binding sites. Expand
Development of a Novel Noncompetitive Antagonist of IL-1 Receptor1
TLDR
Describing the discovery of a potent and specific small (peptide) antagonist of IL-1RI, with properties in line with an allosteric negative modulator, is described. Expand
Luciferase activity under direct ligand-dependent control of a muscarinic acetylcholine receptor
TLDR
The results demonstrate that in engineered GPCR-enzyme chimeras, intracellular enzyme activity can be directly controlled by a G PCR serving as the extracellular ligand-binding domain. Expand
Specific targeting of the IL-23 receptor, using a novel small peptide noncompetitive antagonist, decreases the inflammatory response.
TLDR
The discovery and characterization of a potent IL-23R small-peptide modulator, 2305 (teeeqqly), that is effective in vivo and may complement the actual therapies for these chronic and debilitating inflammatory diseases. Expand
...
1
2
...

References

SHOWING 1-10 OF 45 REFERENCES
Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
TLDR
The discovery that it is possible to increase the affinity of muscarinic receptors for their agonists by allosteric modulators offers a new way to subtype-specific pharmacological enhancement of transmission at cholinergic (muscarinic) synapses. Expand
Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: radioligand binding studies.
TLDR
The results demonstrate the potential for developing allosteric enhancers of acetylcholine affinity at individual subtypes of muscarinic receptor and suggest that minor modification of a compound showing positive, neutral, or low negative cooperativity with acetyl choline may yield compounds with various patterns of cooperativity across the receptor subtypes. Expand
Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies.
TLDR
Functional studies confirm that brucine analogs are allosteric enhancers of ACh affinity at certain muscarinic receptor subtypes. Expand
Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypes.
TLDR
Muscarinic agents may act only on a single muscarinic receptor subtype which is functioning sub-optimally and therefore be of use therapeutically in the early stages of Alzheimer's Disease. Expand
Identification of a [3H]Ligand for the common allosteric site of muscarinic acetylcholine M2 receptors.
TLDR
High affinity binding of [3H]dimethyl-W84 reflects occupation of the common allosteric site of M2 receptors, and is in excellent correlation with their potencies to allosterically stabilize NMS/receptor complexes. Expand
Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
TLDR
Differences between the effects of alcuronium on individual muscarinic receptor subtypes are apparently responsible for differences between the allosteric effects ofAlcur onium on mus carinic receptors in various tissues that had been described previously. Expand
Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3)H]scopolamine and acetylcholine at muscarinic receptor subtypes: identification of a second allosteric site.
TLDR
There are at least two distinct allosteric sites on the M(1) receptor, both of which can support positive cooperativity with acetylcholine, according to equilibrium and nonequilibrium radioligand binding studies. Expand
Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.
Novel methods of detecting and quantitating cooperative interactions between an agent and both a tritiated (muscarinic) antagonist and the endogenous agonist (acetylcholine), acting at a commonExpand
Positive and negative allosteric interactions on muscarinic receptors.
TLDR
A comparison of the five radiolabelled antagonists that have been investigated so far indicates that the type of allosteric interaction (positive or negative) is not determined by the presence or absence of the quaternary nitrogen or of the benzilyl moiety in the molecule of the antagonist. Expand
Competition between positive and negative allosteric effectors on muscarinic receptors.
TLDR
Examination of changes in the binding of [3H]NMS to membranes of rat heart atria exposed to various concentrations of a positive allosteric effector (alcuronium or strychnine) and of a negativeAllostericEffector (gallamine) simultaneously strongly suggests that these positive and negative allosterics effectors bind to identical or overlapping sites. Expand
...
1
2
3
4
5
...